Moderna

Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci speaks during ... [+] the daily briefing on the novel coronavirus, which causes COVID-19, in the Brady Briefing Room of the White House on April 22, 2020, in Washington, DC. (Photo by MANDEL NGAN / AFP) (Photo by MANDEL NGAN/AFP via Getty Images)…

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder(Reuters) - Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc (MRNA.O), fell about 10% on Wednesday, as investor concerns grew about the prospects of…

Moderna's closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday, sending the company's shares surging 30% in premarket trading.Each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine via…

Moderna Inc. (NASDAQ: MRNA) has signed an agreement for a $483 million funding from a federal agency, the biotechnology company announced Thursday. What Happened The funding from the Biomedical Advanced Research and Development Authority will help the company's novel coronavirus (COVID-19) vaccine advance through clinical trials to an approval by the United States Food and…

Moderna's stock was surging Friday after the biotech company announced it has received as much as $483 million in federal funding to accelerate development of a coronavirus vaccine.Shares of the Cambridge, Massachusetts-based firm opened more than 12% higher to around $46. During Thursday's session, the stock hit an intraday all-time high of $41.55.Moderna CEO Stephane Bancel…